Evaluation of the effect of topical sildenafil and diltiazem gel in the treatment of fissures

Phase 3

• Conditions: Anal fissure.; Anal fissure, unspecified; K60.2

• Registration Number: IRCT20181208041882N7
• Lead Sponsor: Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Age 18 to 65 years
Having symptoms includes pain after defecation bleeding or both

Exclusion Criteria

Recurrent fissure
Fissures in an unusual position
No pain

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Onset of pain reduction. Timepoint: This variable was measured after each use of the drug by the patient. Method of measurement: Based on questions from the patient.;Maximum relaxation time. Timepoint: This variable was measured after each use of the drug by the patient. Method of measurement: Visual Analogue Scale.;Duration of treatment. Timepoint: After complete consumption of the drug by the patient and complete recovery. Method of measurement: Based on questions from the patient.;The length of the recovery period. Timepoint: After taking the drug by the patient and that the patient notices a reduction in symptoms after a few days. Method of measurement: Based on questions from the patient.